Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank Disease ID
1 Adherens junction 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
2 Adipocytokine signaling pathway 💬
 [3] CPT1A, CPT1B, CPT1C 💬 D05442 💬 Perhexiline [2] 58, 272 💬
3 Adipocytokine signaling pathway 💬
 [3] CPT1A, CPT1B, CPT1C 💬 D08340 💬 Perhexiline [2] 58, 272 💬
4 Adrenergic signaling in cardiomyocytes 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
5 Adrenergic signaling in cardiomyocytes 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
6 Alcoholic liver disease 💬
 [3] CPT1A, CPT1B, CPT1C 💬 D05442 💬 Perhexiline [2] 58, 272 💬
7 Alcoholic liver disease 💬
 [3] CPT1A, CPT1B, CPT1C 💬 D08340 💬 Perhexiline [2] 58, 272 💬
8 Aldosterone synthesis and secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
9 Aldosterone synthesis and secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
10 Alzheimer disease 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
11 Alzheimer disease 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
12 Amphetamine addiction 💬
 [2] CACNA1C, CACNA1D 💬 D05442 💬 Perhexiline [2] 58, 272 💬
13 Amphetamine addiction 💬
 [2] CACNA1C, CACNA1D 💬 D08340 💬 Perhexiline [2] 58, 272 💬
14 AMPK signaling pathway 💬
 [3] CPT1A, CPT1B, CPT1C 💬 D05442 💬 Perhexiline [2] 58, 272 💬
15 AMPK signaling pathway 💬
 [3] CPT1A, CPT1B, CPT1C 💬 D08340 💬 Perhexiline [2] 58, 272 💬
16 Arrhythmogenic right ventricular cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
17 Arrhythmogenic right ventricular cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
18 Axon guidance 💬
 [2] ABL1, SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
19 Bacterial invasion of epithelial cells 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
20 Bladder cancer 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
21 C-type lectin receptor signaling pathway 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
22 Calcium signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
23 Calcium signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
24 cAMP signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
25 cAMP signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
26 Carbohydrate digestion and absorption 💬
 [1] CACNA1D 💬 D05442 💬 Perhexiline [2] 58, 272 💬
27 Carbohydrate digestion and absorption 💬
 [1] CACNA1D 💬 D08340 💬 Perhexiline [2] 58, 272 💬
28 Cardiac muscle contraction 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
29 Cardiac muscle contraction 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
30 Cell cycle 💬
 [1] ABL1 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
31 Cellular senescence 💬
 [1] CACNA1D 💬 D05442 💬 Perhexiline [2] 58, 272 💬
32 Cellular senescence 💬
 [1] CACNA1D 💬 D08340 💬 Perhexiline [2] 58, 272 💬
33 cGMP-PKG signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
34 cGMP-PKG signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
35 Chemical carcinogenesis - reactive oxygen species 💬
 [2] ABL1, SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
36 Chemical carcinogenesis - receptor activation 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
37 Chemical carcinogenesis - receptor activation 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
38 Chemical carcinogenesis - receptor activation 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
39 Chemokine signaling pathway 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
40 Cholinergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
41 Cholinergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
42 Chronic myeloid leukemia 💬
 [1] ABL1 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
43 Circadian entrainment 💬
 [2] CACNA1C, CACNA1D 💬 D05442 💬 Perhexiline [2] 58, 272 💬
44 Circadian entrainment 💬
 [2] CACNA1C, CACNA1D 💬 D08340 💬 Perhexiline [2] 58, 272 💬
45 Cortisol synthesis and secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
46 Cortisol synthesis and secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
47 Cushing syndrome 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
48 Cushing syndrome 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
49 Diabetic cardiomyopathy 💬
 [2] CPT1B, CPT2 💬 D05442 💬 Perhexiline [2] 58, 272 💬
50 Diabetic cardiomyopathy 💬
 [2] CPT1B, CPT2 💬 D08340 💬 Perhexiline [2] 58, 272 💬
51 Dilated cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
52 Dilated cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
53 Dopaminergic synapse 💬
 [2] CACNA1C, CACNA1D 💬 D05442 💬 Perhexiline [2] 58, 272 💬
54 Dopaminergic synapse 💬
 [2] CACNA1C, CACNA1D 💬 D08340 💬 Perhexiline [2] 58, 272 💬
55 EGFR tyrosine kinase inhibitor resistance 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
56 Endocrine resistance 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
57 Endocytosis 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
58 Epithelial cell signaling in Helicobacter pylori infection 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
59 ErbB signaling pathway 💬
 [2] ABL1, SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
60 Estrogen signaling pathway 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
61 Fatty acid degradation 💬
 [4] CPT1A, CPT1B, CPT1C, CPT2 💬 D05442 💬 Perhexiline [2] 58, 272 💬
62 Fatty acid degradation 💬
 [4] CPT1A, CPT1B, CPT1C, CPT2 💬 D08340 💬 Perhexiline [2] 58, 272 💬
63 Fatty acid metabolism 💬
 [4] CPT1A, CPT1B, CPT1C, CPT2 💬 D05442 💬 Perhexiline [2] 58, 272 💬
64 Fatty acid metabolism 💬
 [4] CPT1A, CPT1B, CPT1C, CPT2 💬 D08340 💬 Perhexiline [2] 58, 272 💬
65 Fluid shear stress and atherosclerosis 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
66 Focal adhesion 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
67 GABAergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
68 GABAergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
69 GABAergic synapse 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00550 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
70 GABAergic synapse 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00696 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
71 GABAergic synapse 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D05028 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
72 GABAergic synapse 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
73 Gap junction 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
74 Glucagon signaling pathway 💬
 [3] CPT1A, CPT1B, CPT1C 💬 D05442 💬 Perhexiline [2] 58, 272 💬
75 Glucagon signaling pathway 💬
 [3] CPT1A, CPT1B, CPT1C 💬 D08340 💬 Perhexiline [2] 58, 272 💬
76 Glutamatergic synapse 💬
 [2] CACNA1C, CACNA1D 💬 D05442 💬 Perhexiline [2] 58, 272 💬
77 Glutamatergic synapse 💬
 [2] CACNA1C, CACNA1D 💬 D08340 💬 Perhexiline [2] 58, 272 💬
78 GnRH secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
79 GnRH secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
80 GnRH signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
81 GnRH signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
82 GnRH signaling pathway 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
83 Growth hormone synthesis, secretion and action 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
84 Growth hormone synthesis, secretion and action 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
85 Hepatitis B 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
86 Herpes simplex virus 1 infection 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
87 Human cytomegalovirus infection 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
88 Hypertrophic cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
89 Hypertrophic cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
90 Inflammatory mediator regulation of TRP channels 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
91 Insulin resistance 💬
 [2] CPT1A, CPT1B 💬 D05442 💬 Perhexiline [2] 58, 272 💬
92 Insulin resistance 💬
 [2] CPT1A, CPT1B 💬 D08340 💬 Perhexiline [2] 58, 272 💬
93 Insulin secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
94 Insulin secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
95 Kaposi sarcoma-associated herpesvirus infection 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
96 Lipid and atherosclerosis 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
97 Long-term potentiation 💬
 [1] CACNA1C 💬 D05442 💬 Perhexiline [2] 58, 272 💬
98 Long-term potentiation 💬
 [1] CACNA1C 💬 D08340 💬 Perhexiline [2] 58, 272 💬
99 MAPK signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
100 MAPK signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
101 MicroRNAs in cancer 💬
 [1] ABL1 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
102 Mitophagy - animal 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
103 Morphine addiction 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00550 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
104 Morphine addiction 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00696 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
105 Morphine addiction 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D05028 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
106 Neuroactive ligand-receptor interaction 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00550 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
107 Neuroactive ligand-receptor interaction 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00696 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
108 Neuroactive ligand-receptor interaction 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D05028 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
109 Neurotrophin signaling pathway 💬
 [1] ABL1 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
110 Neutrophil extracellular trap formation 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
111 Nicotine addiction 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00550 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
112 Nicotine addiction 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00696 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
113 Nicotine addiction 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D05028 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
114 Oxytocin signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
115 Oxytocin signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
116 Oxytocin signaling pathway 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
117 Pathogenic Escherichia coli infection 💬
 [2] ABL1, SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
118 Pathways in cancer 💬
 [1] ABL1 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
119 Pathways of neurodegeneration - multiple diseases 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
120 Pathways of neurodegeneration - multiple diseases 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
121 Platelet activation 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
122 PPAR signaling pathway 💬
 [4] CPT1A, CPT1B, CPT1C, CPT2 💬 D05442 💬 Perhexiline [2] 58, 272 💬
123 PPAR signaling pathway 💬
 [4] CPT1A, CPT1B, CPT1C, CPT2 💬 D08340 💬 Perhexiline [2] 58, 272 💬
124 Prion disease 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
125 Prion disease 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
126 Prolactin signaling pathway 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
127 Proteoglycans in cancer 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
128 Rap1 signaling pathway 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
129 Ras signaling pathway 💬
 [1] ABL1 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
130 Regulation of actin cytoskeleton 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
131 Relaxin signaling pathway 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
132 Renin secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
133 Renin secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
134 Retrograde endocannabinoid signaling 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
135 Retrograde endocannabinoid signaling 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
136 Retrograde endocannabinoid signaling 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00550 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
137 Retrograde endocannabinoid signaling 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00696 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
138 Retrograde endocannabinoid signaling 💬
 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D05028 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
139 Serotonergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
140 Serotonergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
141 Serotonergic synapse 💬
 [3] GABRB1, GABRB2, GABRB3 💬 D00550 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
142 Serotonergic synapse 💬
 [3] GABRB1, GABRB2, GABRB3 💬 D00696 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
143 Serotonergic synapse 💬
 [3] GABRB1, GABRB2, GABRB3 💬 D05028 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
144 Shigellosis 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
145 Taste transduction 💬
 [1] CACNA1C 💬 D05442 💬 Perhexiline [2] 58, 272 💬
146 Taste transduction 💬
 [1] CACNA1C 💬 D08340 💬 Perhexiline [2] 58, 272 💬
147 Taste transduction 💬
 [6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 D00550 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
148 Taste transduction 💬
 [6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 D00696 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
149 Taste transduction 💬
 [6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 D05028 💬 Midazolam [12]  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 272, 298 💬
150 Thermogenesis 💬
 [4] CPT1A, CPT1B, CPT1C, CPT2 💬 D05442 💬 Perhexiline [2] 58, 272 💬
151 Thermogenesis 💬
 [4] CPT1A, CPT1B, CPT1C, CPT2 💬 D08340 💬 Perhexiline [2] 58, 272 💬
152 Thyroid hormone signaling pathway 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
153 Tight junction 💬
 [1] CACNA1D 💬 D05442 💬 Perhexiline [2] 58, 272 💬
154 Tight junction 💬
 [1] CACNA1D 💬 D08340 💬 Perhexiline [2] 58, 272 💬
155 Tight junction 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
156 Tuberculosis 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
157 Type II diabetes mellitus 💬
 [2] CACNA1C, CACNA1D 💬 D05442 💬 Perhexiline [2] 58, 272 💬
158 Type II diabetes mellitus 💬
 [2] CACNA1C, CACNA1D 💬 D08340 💬 Perhexiline [2] 58, 272 💬
159 Vascular smooth muscle contraction 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline [2] 58, 272 💬
160 Vascular smooth muscle contraction 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline [2] 58, 272 💬
161 VEGF signaling pathway 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
162 Viral carcinogenesis 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
163 Viral myocarditis 💬
 [1] ABL1 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬
164 Yersinia infection 💬
 [1] SRC 💬 D09664 💬 Saracatinib [3]  6 , 89, 272 💬

Back to top